Dexcom reports Q4 2022 preliminary revenue at least $815M (+17% YoY); FY2023 guidance $3.35-3.49B

DEXCOM INC

2022-FY EPS reported $0.82 revenue$2,909,800,000

Q4 2022 preliminary revenue at least $815M, up 17% YoY; U.S. $606M, international $209M.
FY2022 preliminary revenue ~$2.91B, up 19% YoY on a reported basis.
FY2023 revenue guidance $3.35B-$3.49B, representing 15-20% growth over 2022.
FY2023 non-GAAP gross profit margin expected 62-63%; non-GAAP operating margin ~16.5%.
CEO cites strong customer growth and G7 CGM regulatory clearances as key drivers.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DEXCOM INC reported fiscal year 2022 results: revenue approximately $2.91 billion.

Period: fiscal year 2022
Revenue: approximately $2.91 billion
Result: preliminary results

Exact text from the filing

total preliminary, unaudited revenue is expected to be approximately $2.91 billion

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DEXCOM INC reported fiscal year 2023 results: revenue approximately $3.35 billion to $3.49 billion. Guidance initiated.

Period: fiscal year 2023
Revenue: approximately $3.35 billion to $3.49 billion
Guidance: initiated
Result: guidance update

Exact text from the filing

initial financial outlook for fiscal year 2023, including an anticipated range for total revenue of approximately $3.35 billion to $3.49 billion

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DEXCOM INC reported the fourth quarter ended December 31, 2022 results: revenue at least $815 million.

Period: the fourth quarter ended December 31, 2022
Revenue: at least $815 million
Result: preliminary results

Exact text from the filing

preliminary, unaudited revenue for the fourth quarter ended December 31, 2022 is expected to be at least $815 million

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

DEXCOM INC filing history →

Source: SEC EDGAR

accession 0001093557-23-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.